Pharmalytik

Pharmalytik is an analytical external services provider. Our goal is to provide high quality technical support to the pharmaceutical industry in various analytical functions within client directives and timelines. Our training program is customized and delivered with the same quality that is being offered at many national scientific meetings.

Pharmalytik is an independent private company found in 2002. It is where quality services delivered with pride.

Pharmalytik provides consulting services in the cGMP and analytical areas for pharmaceutical industry in the past 8 years.

CRO Management

Pharmalytik provides project management oversight for activities at CROs around the globe. Projects include Stability Testing, Method Transfer, Method Validation, CMC documentation.
This is a cost-effective way to manage your CROs and allow your analysts to work on more critical projects.

cGMP Training

Pharmalytik provides technical training in the Pharmaceutical area since 2001. Courses are available to be delivered at your site or customized to fit your needs. Interactive training program is designed for group of 5 to 20 participants.

Trainings, requested via Pharmalytik, will now be organized and offered through United States Pharmacopeia (USP).

On-Site Courses

Pharmalytik provides full on-site trainings. Objectives and Materials will be customized to equip your staff with relevant knowledge to enhance productivity.

Courses, requested via Pharmalytik, will now be organized and offered through United States Pharmacopeia (USP).

Founder & Technical Director

As the founder and technical director of Pharmalytik, Kim Huynh-Ba's expertise focusses in Analytical Development, Method Development/Validation/Transfer, Stability and Outsourcing Project management. She has over 20 years of experiences in various areas of pharmaceutical development working with Wyeth, DuPont Pharmaceuticals, Bristol-Myers Squibb, ICI Americas (currently Astra Zeneca). In 2002, she has started her consulting and training organization. Her current clients include various sizes of pharmaceutical companies including those are under Consent Decree.

Kim Huynh-Ba is an active member of ACS, AAPS, PSDG, ASQ, POMA and serves in the Governing Board of Eastern Analytical Symposium (EAS). She is the founder and past-chair of the AAPS Stability Focus Group, and was on the Steering Committee of AAPS CMC Focus Group. She also is chairing EAS 2008 Short Course Program and AAPS APQ Distance Learning Office.

Kim Huynh-Ba received the 2008 Leadership Award from APQ and the 2008 Recognition Award from AAPS Regulatory Sciences.

“Save on time! Save on travel! Same Quality!”